SO
About
Swedish Orphan Biovitrum engages in the development, marketing, and distribution of orphan products and specialty pharmaceuticals. It offers drugs for the treatment of rare and life-threatening diseases, such as cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, palliative care, poison control, respiratory diseases, and urology.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 10 investors are based in Solna, Stockholms Lan, Sweden.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Solna, Sweden
Contact Information
linkedin.com/in/••••••••
Find more investors like Swedish
Search Investors